Longeveron Alzheimer’s Disease Trial

Longeveron Alzheimer’s Disease Trial

by | Jan 21, 2018 | News & Opinions, Science

Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem...